LKB1/STK11, however, is rarely involved in sporadic colon cancer cases and at most 33% of NSCLC cases (Sanchez-Cespedes et al, 2002), leading us to consider the role of MBD3 as an alternative tumour-suppressor gene on this location. The gene discussed is MBD3; the disease is colonic neoplasm.